Description
What is the future of synthetic biology? What approaches will work in the marketplace for vendors? Bioinformatics has spoken to authorities in the market in the public and private sectors and compiled a report. 
To gather the latest insights in synthetic biology you might have to attend expensive conferences or reach out to universities and companies to seek key leader opinion. Bioinformatics has done the work for you.
Use This Report to Gain Insights:
- Understand the needs and considerations of customers buying synthetic DNA products/services.
- Know where and how to best reach Synthetic Biologists.
- Discover the top challenges Synthetic Biologists face.
- Learn what the top cited important skills are for the next generation to have.
- Find out what companies are succeeding and getting noticed.
- Inform strategies to be a better brand partner to Synthetic Biologists.
- Speak the language of scientists in the field and align your business efforts accordingly.
This report is a work of qualitative research, reflective of the skills and professionalism of the Qualitative Research Group of Science and Medicine Group. The report demonstrates how a series of long-form interviews with research subjects can help your company make business plans. Services for a customized project are always available.
Companies and institutions mentioned in this report include:
- Fujifilm (Diosynth Biotechnologies)
- LabGenius
- Seawolf Therapeutics
- Boeringer Ingelheim
- Scarab Genomics
- Qiagen
- Mammoth Biosciences
- Syngoi
- Cartograhy Biosciences
- Grace Science
- Netrias
- Cargill
- Yale University School of Medicine
- Newcastle University
- Queen’s University Belfast
- University of Freiburg
- University of Essex
- UCSF School of Medicine
- Eurofins
- Color
- Plasmidsaurus
- Primordium
- Integrated DNA Technologies
- Twist Bioscience
- GenScript
- GENEWIZ
- ATUM Bio (Formerly DNA 2.0)
- Synthego
